Great. Thanks, M.J. And good morning. Thank you for joining us today for our 2024 Third Quarter Conference Call. On the call with me today is Bill Monroe, our Chief Financial Officer; Leigh Ann Stach, our Chief Accounting Officer; and Tim Meyer, our EVP of Asset Management. Our earnings announcement and supplemental data report were released last night and furnished on Form 8-K, along with our quarterly report on 10-Q. In addition, an updated investor presentation was posted to our website last night. Numerous people and businesses were severely impacted and even devastated by hurricanes Helene and Milton. Many in Florida, Western North Carolina, and East Tennessee have experienced unprecedented flooding and damage that will require months for full recovery. Although some of our tenants encountered power outages, downed trees, and other inconveniences, we were fortunate that our properties did not sustain damage from the storms. As was previously announced, we successfully increased our revolving credit facility from $150 million to $400 million, extended its maturity date five years, all while achieving lower pricing. Bill will go into more detail in his remarks, but we were very pleased with the support of our bank group, which gives credence to the overall strength and stability of CHCT. Also, I wanted to provide an update on the geriatric psychiatric hospital operator, who is a tenant in six of our properties, representing a total of approximately 79,000 square feet and base rent of $3.2 million. Although we are not yet receiving rent and interest from the tenant, the operator's consulting team has stabilized hospital staffing, reduced costs and improved processes and controls. As a result, we are seeing improved census in October. Although we do not yet know the timing or amounts the tenant may be able to pay, we continue to pursue multiple parallel paths to begin receiving rent and interest payments as soon as possible. We remain in active dialogue with the operator and its consultants and will continue to evaluate all options available to us under our leases and notes. As for the other components of the business, our occupancy decreased from 92.6% to 91.3% during the quarter, related to a couple of lease terminations and expirations, but we continue to see good leasing activity in the portfolio. In addition, we have five properties or significant portions of them that are undergoing redevelopment or significant renovations with long-term tenants in place when the renovations or redevelopment is completed. We expect three of these projects to commence their leases during the first quarter of 2025. Our weighted average remaining lease term decreased slightly from 7.1 years to 6.8 years. And during the quarter, we acquired one physician clinic for a purchase price of approximately $6.2 million and an expected return of approximately 9.3%. The property is 100% leased with a lease expiration in 2027. We have four properties under definitive purchase agreements for an aggregate expected purchase price of $8.8 million. The company's expected returns on these investments range from 9.29% to 9.5%. We expect to close on these properties in the fourth quarter of 2024. Also, the company has signed definitive purchase and sale agreements for seven properties to be acquired after completion and occupancy for an aggregate expected investment of $169.5 million. The expected return on these investments should range from 9.1% to 9.75%. We anticipate closing on these properties throughout 2025, 2026, and 2027. Despite having access to our ATM last quarter, we did not sell equity at our currently depressed share price. Given the low share price, we are actively evaluating capital recycling opportunities, and we would anticipate having sufficient capital from selected asset sales coupled with our increased revolver capacity to fund near-term acquisitions. Going forward, we will evaluate the best uses of our capital, including, if authorized, potential share repurchases, all while maintaining modest leverage levels. To wrap up, we declared our dividend for the third quarter and raised it to $46.5 cents per common share. This equates to an annualized dividend of $1.86 per share, and we are proud to have raised our dividend every quarter since our IPO. That takes care of the items I wanted to cover, so I will hand things off to Bill to discuss the numbers.